New Drug Approved for Early Alzheimer’s

https://ift.tt/wQevrTn drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

from NYT > Top Stories https://ift.tt/PXiv9jO